Omega Therapeutics IPO Presentation Deck
IPO Offering Summary
Issuer (Exchange / Ticker)
Omega Therapeutics, Inc. (NASDAQ Global Market / OMGA)
Base Offering Size
$125 million (100% primary)
Shares Offered
7,400,000 shares (100% primary)
Option to Purchase Additional 1,110,000 shares (100% primary)
Shares
Price Range
Lock-Up Period
Use of Proceeds
Bookrunners
Stabilization Agent
Expected Pricing Date
Ⓒ2021 Omega Therapeutics, Inc.
$16.00-$18.00 per share
180 day lock up of the Company, Directors, Officers, and Substantially All Shareholders
Omega Therapeutics intends to use the net proceeds from the offering as follows:
to support Omega's continued research and development of its OECS
to support IND-enabling studies and the potential initiation of clinical studies
to continue advancing the OMEGA Epigenomic Programming Platform and discovery-stage
research for other potential programs
to build out a manufacturing facility
for working capital and other general corporate purposes
Goldman Sachs & Co. LLC, Jefferies LLC, Piper Sandler & Co., Wedbush Securities Inc.
Goldman Sachs & Co. LLC
Thursday, July 29, 2021View entire presentation